| Not Yet Recruiting | Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease NCT07180745 | Badr University | Phase 4 |
| Not Yet Recruiting | Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on L NCT06727279 | Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology | N/A |
| Recruiting | Exploratory Study of MRI Biomarkers of NASH NCT06626074 | University Hospital, Angers | N/A |
| Recruiting | Evaluation of Miricorilant on Liver Fat in Patients With MASLD NCT06947304 | Corcept Therapeutics | Phase 1 |
| Enrolling By Invitation | Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease NCT06942312 | Helsinki University Central Hospital | — |
| Recruiting | A Phase 1b Study of QX1206 in T2DM Patients With NAFLD NCT06694935 | 1Globe Health Institute | Phase 1 |
| Active Not Recruiting | Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers NCT07172997 | Royal College of Surgeons in Ireland - Medical University of Bahrain | — |
| Recruiting | Milk Thistle Clinical Trial in Pediatric NAFLD NCT06477146 | University Hospitals Cleveland Medical Center | Phase 2 |
| Not Yet Recruiting | Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disea NCT06627114 | Hawler Medical University | N/A |
| Not Yet Recruiting | Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS) NCT06623084 | Stefania Basili | — |
| Enrolling By Invitation | Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans NCT06559878 | Helsinki University Central Hospital | N/A |
| Active Not Recruiting | The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohep NCT06913699 | Shanghai East Hospital | — |
| Active Not Recruiting | Non-Invasive Diagnostic Tests for MASLD in Pediatric Population NCT06218589 | Emory University | N/A |
| Active Not Recruiting | Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for NCT05384652 | Chinese University of Hong Kong | — |
| Unknown | Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Dise NCT05908006 | GI Alliance | — |
| Completed | Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices NCT07268937 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Completed | Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD) NCT06127225 | Dexa Medica Group | Phase 2 |
| Recruiting | Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients NCT05699018 | University Hospital, Angers | N/A |
| Recruiting | Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease NCT07265544 | Nanfang Hospital, Southern Medical University | — |
| Completed | The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic F NCT06338449 | Xuzhou Medical University | N/A |
| Completed | Study to Evaluate the Effectiveness of Legalon® NCT05051527 | Mylan Inc. | — |
| Active Not Recruiting | Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (A NCT04835831 | Centre Hospitalier Universitaire de Nice | N/A |
| Unknown | Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver Di NCT04946786 | Sohag University | — |
| Active Not Recruiting | A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) NCT04820036 | Brigham and Women's Hospital | N/A |
| Active Not Recruiting | Combined Active Treatment in Type 2 Diabetes with NASH NCT04639414 | German Diabetes Center | Phase 4 |
| Completed | NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patient NCT06688149 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | N/A |
| Unknown | The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF NCT04682600 | Sonic Incytes | N/A |
| Unknown | Metabolic Surgery for Steato-Hepatitis NCT04282005 | King's College London | N/A |
| Completed | Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER NCT04165343 | University of California, Davis | — |
| Unknown | Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence. NCT04099147 | Instituto de Investigación Marqués de Valdecilla | — |
| Completed | A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. NCT04019561 | MedImmune LLC | Phase 2 |
| Completed | Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease NCT04330326 | ScandiBio Therapeutics AB | Phase 2 |
| Completed | A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For NCT03776175 | Pfizer | Phase 2 |
| Recruiting | Longitudinal Observational Study Of Chinese With NAFLD/NASH NCT03151473 | Humanity and Health Research Centre | — |
| Active Not Recruiting | Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study NCT02754037 | University of California, Davis | — |
| Terminated | Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease ( NCT02605616 | University of Alabama at Birmingham | Phase 2 |
| Completed | A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweigh NCT02354976 | AstraZeneca | Phase 2 |
| Withdrawn | Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study NCT02457286 | Northwell Health | Phase 1 |
| Completed | Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD NCT04450875 | Universidad Veracruzana | N/A |
| Completed | "Hepafast" in Non-alcoholic Fatty Liver Disease (NAFLD) NCT02491229 | University of Hohenheim | N/A |
| Withdrawn | The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients NCT02194894 | University of Southern California | N/A |
| Unknown | Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insul NCT02654665 | Changi General Hospital | Phase 3 |
| Completed | Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver NCT01477307 | University Hospital, Geneva | — |
| Completed | Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients NCT01811472 | Novartis Pharmaceuticals | Phase 2 |
| Active Not Recruiting | Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk NCT02037321 | John Sievenpiper | — |
| Completed | Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus NCT01997424 | Johann Wolfgang Goethe University Hospital | N/A |
| Completed | Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease NCT01894438 | Harokopio University | N/A |
| Completed | Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD) NCT01418027 | Shanghai Jiao Tong University School of Medicine | Phase 3 |
| Completed | Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-17 NCT01110577 | Merck Sharp & Dohme LLC | — |
| Completed | Regulation of FGF21 by Nutritional Challenges NCT00968747 | Beth Israel Deaconess Medical Center | N/A |
| Completed | How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)? NCT01790984 | Bruce A. Griffin | N/A |
| Unknown | Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric Patients NCT02201160 | St. Justine's Hospital | Phase 1 / Phase 2 |
| Withdrawn | Non Alcoholic Fatty Liver Disease Influence of Statin Therapy NCT00375349 | Shaare Zedek Medical Center | N/A |
| Completed | Exercise Dose and Nonalcoholic Fatty Liver Disease NCT00771108 | Washington University School of Medicine | N/A |